InvestorsHub Logo
Followers 129
Posts 3809
Boards Moderated 0
Alias Born 07/12/2003

Re: None

Wednesday, 06/09/2021 12:35:02 PM

Wednesday, June 09, 2021 12:35:02 PM

Post# of 113754
The news is just an update of on-going studies. They are going well and hopefully sooner than we can get them completed and get an application to the FDA for Human testing. PFizer has a similar product that is already in human trials which is a plus for us when we go to the FDA with our application. Many different drugs will be created to treat Covid-19 however Pfizer's and Sunshine's are the only two I know of (there are most likely more) that come in a pill form.

The pill form will be a "game changer" as one would not have to go to the hospital or have a health care provider present to administer the treatment as must be done for current antiviral drug via a needle in the skin (intravenously). Also the pill will probably be cheaper to make, transport and have a longer shelf life.

The BOTTOM LINE is just simply HUGE!!!

That being said the Covid-19 is just the appetizer, the MAIN COURSE is the CANCER treatments that are in development.

Montreal, Quebec, Canada – (GLOBE NEWSWIRE) – Sunshine Biopharma Inc. (OTC PINK: “SBFM”), a pharmaceutical company focused on the research, development and commercialization of oncology and antiviral drugs; today confirmed that its COVID-19 mice study currently underway at the University of Georgia is progressing as planned. The study assesses the efficacy of two protease inhibitors in preventing transgenic mice challenged with SARS-CoV-2 from progressing to illness and death. Should these studies prove successful, the Company plans to file the data with the FDA and request authorization to do testing in actual COVID-19 patients. Sunshine Biopharma’s protease inhibitor treatment is anticipated to be orally available, making it possible for the treatment to be in tablet form, which can be taken at home.

“We are moving the project forward as fast as possible, albeit within the constraints of science,” said Dr. Steve Slilaty, CEO of Sunshine Biopharma. “We are optimistic that our research efforts will culminate in a drug that will help turn the page on the pandemic,” he added.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent SBFM News